. | . |
Pfizer says Omicron booster is effective against BA.5 COVID-19 subvariant by Patrick Hilsman Washington DC (UPI) Oct 13, 2021 Pfizer and its German partner BioNTech announced on Thursday that their Omicron booster shots substantially increased antibody protection against the BA.5 subvariant of COVID-19 in preliminary tests. "The early data suggest that our bivalent vaccine is anticipated to provide better protection against currently circulating variants than the original vaccine,"Pfizer CEO Albert Bourla said in a press statement. The initial results come from blood samples taken from 40 people between the ages of 18 and 55 and 40 people over the age of 55. Pfizer says there was a substantial boost in antibody protection against the BA.5 subvariant in both groups. Further data collected from a group of 40 individuals over the age of 55 who had received first generation boosters, but not the omicron-specific booster, indicated only a limited increase in antibodies against BA.5. The new data is valuable because the Food and Drug Administration approved the Omicron boosters in September without human data on how effectively they would increase antibodies against the BA.5 subvariant of COVID-19. The preliminary data on BA.5 antibodies from Pfizer's omicron booster comes after the Food and Drug Administration approved its use in children aged 5-11 on Wednesday. Pfizer says that their Omicron booster is safe in a way that is comparable to prior COVID-19 vaccines.
Chinese state media signals no end to zero-Covid curbs Beijing (AFP) Oct 12, 2022 China's state media on Wednesday signalled no let-up in its strict zero-Covid policy, publishing an editorial - the fourth this week ahead of the Communist Party Congress - vowing to never "lie flat" on virus controls. The messaging dashes widespread hopes from the Chinese public and overseas observers that the strategy might be relaxed after the congress, a twice-a-decade political reshuffle which begins Sunday and will set the blueprint for the country's development. China is the last major ... read more
|
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |